An Introduction to Prescribing Narinder Bhalla Lead Pharmacist – Clinical Governance Addenbrooke’s NHS Trust November 2006.

Slides:



Advertisements
Similar presentations
Warfarin, Insulin and Digoxin are the most Dangerous drugs in the elderly. Do we believe that?
Advertisements

Medication Management
The management of adverse drug reactions I Ralph Edwards
COMMUNITY PHARMACY WORKBOOK PUBLIC HEALTH DORSET
National Adult Clozapine Titration Chart
CQC registration for providers of Primary Dental Services Medicines Management Caroline Crouch NHS Dorset.
What’s different about paediatric prescribing.  Vary in their developmental stages ◦ Pre-term, neonates, infants, children, adolescents  Dynamic anatomy.
Drug Utilization Review (DUR)
Guidelines for Pain Management Paula Wilkinson Chief Pharmacist NHS Mid-Essex.
GOOD PHARMACY PRACTICE
Instructions say P.O. q 4 h prn pain.
MEDICATION SAFETY: Clozapine Initiation Chart Review
Clinical pharmacy Dr. Mohammed Al-Rekabi Lecture One First Semester.
Standard 4: Medication Safety Advice Centre Network Meeting Margaret Duguid Pharmaceutical Advisor February 2013.
Drug safety in the elderly EFNS Stockholm 2012 Barbro Westerholm Prof.em, Member of Swedish Parliament.
Australian Commission on Safety and Quality in Health Care
Dr. Rosaline Kinuthia Clinical pharmacist KNH. Optimize patients outcomes through the judicious, safe, efficacious, appropriate and cost effective use.
Pharmacist Anna Santamäki Helsinki University Hospital Pharmacy HUS Children’s Hospital
Medication/ Medication Administration
Social Pharmacy Lecture no. 8 Rational prescribing guidelines.
MEDICATION ADMINISTRATION Topic 1A Drug Schedules.
Responsibilities and Principles of Drug Administration
Prescribing Errors in General Practice The PRACtICe Study (2012) GMC Investigating Prevalence and Causes.
Introducing the Medication Recording System Schedule Ed Castagna Mom & Pop’s Small Business Services.
Clinical Pharmacy Part 2
Investigational Drugs in the hospital. + What is Investigational Drug? Investigational or experimental drugs are new drugs that have not yet been approved.
Introduction to Pharmacology PHARM TECH. Pharmacology  Pharmacology is the science that deals with the study of therapeutic (beneficial) agents.  Knowledge.
Rational Prescribing & Prescription Writing Collected and Prepared By S.Bohlooli, Pharm.D, PhD.
Dispensing &compounding Prepared by: Kazi Rashidul Azam.
Fundamentals of Nursing Care: Concepts, Connections, & Skills Copyright © 2011 F.A. Davis Company Chapter 35 Researching and Preparing Medications.
Standard 4: Medication Safety Advice Centre Network Meeting Margaret Duguid Pharmaceutical Advisor February 2013.
Problems of Polypharmacy
Administration Safety PHCL 492. Standards for Medicines Management  ‘When required to administer medication a practitioner is accountable for his or.
CD ROMs for Pharmaceutical use Patrick Bongo BSc (Hons), MSc, PGCE, MBCS.
Introduction to Pharmacology. Nurse Practice Act Defines scope Role of the LPN.
Author Name: Kannika Inpra Presenter Name: Kannika Inpra Authors: Inpra K., Suwankesawong W., Kaewvichit S. Institution: Phrae.
ABSTRACT Title: Developing National Formularies Based on the WHO Model Formulary Authors: Tisocki K 3, Laing RL 1, Hogerzeil H 1, Mehta DK 2, Ryan RSM.
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 2 Application of Pharmacology in Nursing Practice.
Principles of Medication Administration and Medication Safety Chapter 7 Mosby items and derived items © 2010, 2007, 2004 by Mosby, Inc., an affiliate of.
Emtenan AlHarbi,Mcs Clinical pharmacist
Quality Education for a Healthier Scotland Pharmacy Pharmaceutical Care Planning Vocational Training Scheme: Level = Stage 2 Arlene Shaw Specialist Clinical.
Introduction.
Pharmacology and the Nursing Process in LPN Practice
Agenda BupaPrivate and Confidential Implementing a training and accreditation scheme for TTA pre-pack dispensing R Betmouni, N Gillani Pharmacy Department,
Medicines Management Quick Quiz. 1.Staff administering medicines, if not doctors or pharmacist, do not need to know about the medicines they are administering.
Introduction to BNF and Prescribing ICL – 3 rd year medical students.
Pharmacy Service role in supporting informal carers Inverclyde Pharmacy Change Plan Natalie O’Gorman.
Workshop to introduce local selection of monographs from national midwifery formulary.
Safe Prescribing TRUST NAME: September 2011 Insert Specialty School of Paediatrics and Child Health.
Cellulitis (1/4) 1 Admission criteria Patient able to attend Ambulatory Care as an outpatient day 3 & 7 as a minimum? If patient immobile can community.
Using the BNF CWFS F1 Programme Safe Prescribing Module.
Documentation in Practice Dept. of Clinical Pharmacy.
E-Prescriptions Krishi. E-Prescriptions Overview One major contributor to PAEs is patient medication errors, and the implementation of e-prescription.
At a Glance: Omitted Doses 1. Before signing the drug chart, ask… Why is the patient unable to take the dose? Is this medicine a time critical medicine?
Prescription and referral making
Meet & Greet. Welcome Objectives: 1. Review the core terminology used in pharmacology. 2. Discuss the features of the “perfect” drug. 3. Examine the.
Medicines Authority 203,Level 3, Rue D’Argens, Gzira,GZR 1368 Tel: (+356) Fax: (+356) ov.mt Reporting.
COMMUNITY PHARMACY WORKBOOK PUBLIC HEALTH DORSET
Antibiotics: handle with care!
Prescribing.
DRUG PRESCRIBING.
Medication Safety Dr. Kanar Hidayat
Application of Pharmacology in Nursing Practice
PROSES TERAPI DAN PERMASALAHANNYA
Medication Safety Dr. Kanar Hidayat
APOLLOJAMES LECTURER NANDHA COLLEGE OF PHARMACY
COMMUNITY PHARMACY WORKBOOK 2019 PUBLIC HEALTH DORSET
Hospital pharmacy.
Let’s talk medicines safety
Presentation transcript:

An Introduction to Prescribing Narinder Bhalla Lead Pharmacist – Clinical Governance Addenbrooke’s NHS Trust November 2006

Objectives  What is prescribing?  Responsibilities of the prescriber  Good prescribing principles  Using the BNF and other info sources  Principles of prescribing in special groups

When it goes wrong

What is prescribing  Writing/generation of a prescription for a drug (paper or electronic).  Verbal order for a drug to be administered on doctor’s advice.

Responsibilities of the prescriber  If you prescribe a drug you are clinically and legally responsible for your actions.  If you are asked to prescribe the drug, it is the person who signs the prescription who is responsible

n Right Patient n Right Drug n Right Dose n Right Route n Right Time Responsibilities of the prescriber

 Only prescribe medicines that you are competent to prescribe. (knowledge of drug indication, action, dosing, side-effects, interactions). (knowledge of drug indication, action, dosing, side-effects, interactions).  Only prescribe medicines if they are necessary  Prescribe only if benefits of medication outweigh the risks  Discuss treatment options with the patients/concordance  Indicate likely/degree of benefit (efficacy), onset and duration  Discuss side-effects/tolerability

Concordance (  The prescriber and the patient should agree on the health outcomes and the strategy for achieving them.  Consider religious, cultural and personal beliefs that may affect acceptance of medicines.  Keep drug regimes simple and review regularly  Combination treatments only if benefits outweigh risks (restrict ability to titrate doses).

Principles of Good Prescribing  State patient details clearly (name, address, date of birth, age (children/elderly).  Take account of any allergies and complete relevant paperwork.  Use generic drug names  State drug, dose, strength, route and frequency  Avoid abbreviations  Avoid multiple route prescribing (i.e. im/sc/po)  State dose as grams, mg, mcg.  Make administration of once weekly drugs clear

Generic Prescribing  Prescribe by the approved drug name  Ensures clarity regarding drug required  Ensures that the most-cost effective version of the drug can be supplied.

Commonly Used latin abbreviations ac.- ante cibum (before food) bd.- bis die (twice daily) od.- omne die (once daily) om.- -omni mane (every morning) on.- omni nocte (every night) tds- ter die sumendus (to be taken three times daily tid- ter in die (three times daily) pc.- post cibum (after food) prn- pro re nata (when required) qds- quarter die sumendus (to be taken four times daily times daily

Types of prescription  FP10 (white) Standard NHS prescription issued by GPs that can be dispensed by a pharmacy registered to dispense NHS prescriptions  FP10(HP) Yellow NHS prescription issued by hospitals, that can be dispensed by a registered pharmacy.  FP10P Nurse prescriber’s NHS prescriptions that can be dispensed by a registered pharmacy.

Types of prescription  Hospital prescriptions Outpatient clinic prescriptions Main drug chart Anticoagulant chart Diabetic chart IV chart

Factors affecting prescribing  Patient’s clinical state  Concomitant disease  Severity of current disease  Available treatments (consider likely outcomes (patient oriented outcomes)/quality of life). (consider likely outcomes (patient oriented outcomes)/quality of life).  Likely efficacy of treatments  Side-effects/tolerability  Interactions (drugs and food)  Compliance/health benefits

British National Formulary (BNF)  Front section  Prescribing guidance, prescription writing & CD prescribing  Prescribing in children, elderly & palliative care  Emergency treatment of poisoning Middle section  Approved Drug Name with indications, S/E, cautions & dose Back section  Appendixes: interaction, pregnancy  Abbreviations used in the BNF (BNF Back page)

BNF ( The main text consists of classified notes on clinical conditions, drugs and preparations. These notes are divided into 15 chapters, each of which is related to a particular system of the body or to an aspect of medical care. Chapter 1: Gastrointestinal system Chapter 2: Cardiovascular system Chapter 3: Respiratory system Chapter 4: Central Nervous System Chapter 5: Infections Chapter 6: Endocrine system Chatper 7: Obs and Gynae and Urinary tract disorders Chapter 8: Malignant disease and immunosuppression Chapter 9: Nutrition and blood Chapter 10: Musculoskeletal and joint disorders Chapter 11: Eye Chapter 12: ENT Chapter 13: Skin Chapter 14: immunological products and vaccines Chapter 15: Anaesthesia

Drug listings in the BNF Drug Name Indications: (details of use and indications) Cautions: details of precautions required (with cross-references to appropriate Appendixes) and also any monitoring required. Contra-indications: details of any contra- indications to use of the drug. Side-effects: details of common and more serious side-effects. Dose: dose and frequency of administration (max dose); Child and Elderly details of dose for specific age group. By alternative route, dose and frequency. Approved name: form, pack size and price. Proprietary name: form, pack size and price.

BNF Appendixes Appendix 1-Drug Interactions  A black dot symbol is placed against those interactions that are potentially hazardous.  Interactions listed by drug/drug class in alphabetical order.

BNF Appendixes Appendix 2  Table of drugs to be avoided or used with caution in liver disease Appendix 3  Principles of dose adjustment in renal impairment  GFR values  Table of drugs to be avoided or used with caution in renal impairment

BNF Appendixes Appendixes 4 and 5  Prescribing in pregnancy and breast feeding Appendix 6 Intravenous additives  Table of common drugs given IV and how to prepare, dilute and administer them. prepare, dilute and administer them.

Yellow Card Reporting Doctors, nurses, pharmacists and patients may complete a yellow card report Report 1. All suspected reactions to new medicines (black triangle) 2. All serious suspected reactions to established medicines 3. Report all serious and minor reactions in children (<18yrs).

Sources of Prescribing Info  Trust Prescribing Policy  BNF/eBNF  IV guides/monographs  Trust Formulary  Specialist references (e.g. Paediatric)  Summary of Product Characteristics  Pharmacist  Medicines Information  Electronic access to central library of Trust approved guidelines.

Prescribing for children  Children are not little adults  Many drugs not licensed for use in children  Use a specialist children's formulary “BNF for Children”.  Weights and occasionally surface areas are required to calculate accurate doses. These parameters may change significantly in a relatively small time period. to calculate accurate doses. These parameters may change significantly in a relatively small time period.

Prescribing for Children  Pharmacokinetic changes in childhood are important and have a significant influence on drug handling.  The availability of a product does not ensure its suitability for use in children.

Prescribing for the Elderly  18% of the population are over 65yrs age.  Receive 1/3 of NHS prescriptions  Absorption, metabolism, distribution and elimination of drugs affected by ageing.  Renal function deteriorates with age.  Alzheimer’s disease, dementia and other cognitive disorders, Parkinson's disease are important disorders in the elderly.  Drugs such as NSAIDS, opioids, benzodiazepines etc are likely to cause problems in the elderly.

Prescribing for the Elderly Principles of prescribing  Avoid unnecessary drug therapy  Effect of treatment on quality of life  Treat the cause rather than the symptom  Drug history  Concomitant medical illness  Choice of drug  Dose titration  Dosage form  Packaging and labelling  Good record keeping  Regular review

Formularies & ‘Essential’ Drugs  National formularies (e.g. the BNF) provide an independent source of advice.  Hospital formularies reflect hospital choices, based on evidence based and cost-effective evaluation of the evidence base for a drug.  WHO provide a ‘model’ list of essential drugs (~300 items).

Common Prescribing Errors  Wrong drug (e.g. drugs that sound alike)  Wrong dose  Inappropriate Units  Poor/illegible prescriptions  Failure to take account of drug interactions  Omission  Wrong route/multiple routes (IV/SC?PO)  Calculation errors (important in Paediatrics)  Poor cross referencing  Infusions with not enough details of diluent, rate etc. Poor cross-referencing between charts  Once weekly drugs  Multiple dose changes